Impact of Completeness of Revascularization on Long-Term Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus
Author(s) -
Leonard Schwartz,
Marnie Bertolet,
Frederick Feit,
Francisco Fuentes,
Edward Y. Sako,
Mehrdad Seilanian Toosi,
Charles J. Davidson,
Fumiaki Ikeno,
Spencer B. King
Publication year - 2012
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.111.963512
Subject(s) - medicine , revascularization , cardiology , percutaneous coronary intervention , coronary artery disease , diabetes mellitus , hazard ratio , angioplasty , surgery , myocardial infarction , confidence interval , endocrinology
Patients with diabetes have more extensive coronary disease than those without diabetes, resulting in more challenging percutaneous coronary intervention or surgical (coronary artery bypass graft) revascularization and more residual jeopardized myocardium. The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial provided an opportunity to examine the long-term clinical impact of completeness of revascularization in patients with diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom